EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia

Alexander C Lewis, Emily Gruber, Rheana Franich, Jessica Armstrong, Madison J Kelly, Carlos M Opazo, Yau C Low, Léa Flippe, Kevin Wijanarko, Caitlin L Rowe, Celeste H Mawal, Alexandra Birrell und 18 weitere

Cell · 2026-01 · 189 (1) · 215-232.e24

DOI: 10.1016/j.cell.2025.10.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2026-01. Verfasst von Alexander C Lewis und 29 weiteren Autor:innen. Beteiligte Einrichtung: Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 30…. Hauptthemen laut MEDLINE: Heme, Leukemia, Myeloid, Acute, Copper. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council, Cancer Council Victoria, Victorian Cancer Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ubiquitous metabolite heme has diverse enzymatic and signaling functions in most mammalian cells. Through integrated analyses of mouse models, human cell lines, and primary patient samples, we identify de novo heme biosynthesis as a selective dependency in acute myeloid leukemia (AML). The dependency is underpinned by a propensity of AML cells, and especially leukemic stem cells (LSCs), to downregulate heme biosynthesis enzymes (HBEs), which promotes their self-renewal. Inhibition of HBEs causes the collapse of mitochondrial Complex IV and dysregulates the copper-chaperone system, inducing cuproptosis, a form of programmed cell death brought about by the oligomerization of lipoylated proteins by copper. Moreover, we identify pathways that are synthetic lethal with heme biosynthesis, including glycolysis, which can be leveraged for combination strategies. Altogether, our work uncovers a heme rheostat that is connected to gene expression and drug sensitivity in AML and implicates HBE inhibition as a trigger of cuproptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemeLeukemia, Myeloid, AcuteCopperHumansAnimalsMiceCell Line, TumorNeoplastic Stem CellsApoptosisMitochondria

Stichwörter der Autor:innen

acute myeloid leukemiacuproptosisheme biosynthesismetabolic vulnerabilitymetabolismmitochondrial Complex IV

Substanzen

HemeCopper

Autor:innen und Institutionen

  • Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3010, Australia.
  • Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
  • Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC 3010, Australia.
  • Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia.
  • Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC 3010, Australia; The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW…
  • Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia; The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.

Förderung

  • National Health and Medical Research Council
  • Cancer Council Victoria
  • Victorian Cancer Agency
  • Mito Foundation
  • Cure Cancer Australia Foundation

Zitieren

APA

Lewis, A. C., Gruber, E., Franich, R., Armstrong, J., Kelly, M. J., Opazo, C. M., Low, Y. C., Flippe, L., Wijanarko, K., Rowe, C. L., Mawal, C. H., Birrell, A., So, J., Vaidyanathan, S., Ting, K., Semcesen, L. N., Last, K., Ang, C. S., Pomilio, G., …, & Kats, L. M. (2026). Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia. Cell, 189(1), 215-232.e24. https://doi.org/10.1016/j.cell.2025.10.028

Vancouver

Lewis AC, Gruber E, Franich R, Armstrong J, Kelly MJ, Opazo CM, et al. Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia. Cell. 2026;189(1):215-232.e24. doi:10.1016/j.cell.2025.10.028

BibTeX
@article{Lewis2026,
  author = {Lewis, Alexander C and Gruber, Emily and Franich, Rheana and Armstrong, Jessica and Kelly, Madison J and Opazo, Carlos M and Low, Yau C and Flippe, Léa and Wijanarko, Kevin and Rowe, Caitlin L and Mawal, Celeste H and Birrell, Alexandra and So, Joan and Vaidyanathan, Srimayee and Ting, Keziah and Semcesen, Liana N and Last, Karena and Ang, Ching-Seng and Pomilio, Giovanna and Brown, Fiona C and Wei, Andrew H and Powell, Jason A and Ng, Elizabeth S and Frazier, Ann E and McArthur, Kate and Lalaoui, Najoua and Stroud, David A and Brown, Kristin K and Johnstone, Ricky W and Kats, Lev M},
  title = {Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia},
  journal = {Cell},
  year = {2026},
  volume = {189},
  number = {1},
  pages = {215--232.e24},
  doi = {10.1016/j.cell.2025.10.028}
}
Kostenlos starten →